CompletedNot Applicable

Treatment of Congenital Stationary Night Blindness With an Alga Containing High Dose of Beta Carotene

Israel7 participantsStarted 2007-07

Plain-language summary

To assess the effect of oral administration of the alga Dunaliella bardawil containing approximately 50% all-trans beta-carotene and 50% 9-cis beta-carotene isomers on visual functions patients with Congenital Stationary Night Blindness {Fundus albipunctatus).

Who can participate

Age range18 Years – 75 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Isolated rod response markedly reduced (less than 20% of normal)after 20 minutes dark adaptation and improved by 50% after 2 hours
✓. Negative maximal response (a wave to b wave ratio less than 2)
✓. Retinal midperipheral white dots (More than 3000 dots)

What they're measuring

Electroretinogram responses

Timeframe: Three months

Trial details

NCT IDNCT00569023

SponsorSheba Medical Center

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2009-08

View on ClinicalTrials.gov More Night Blindness trials